Literature DB >> 1028122

Plasma volume expansion after infusion of 5%, 20% and 25% albumin solutions in patients.

L O Lamke, S O Liljedahl.   

Abstract

Fifty grams of albumin were infused into patients in the immediate post-operative period as either 5, 20 or 25% solutions. With all three solutions the increase in plasma volume was 500 ml or 11 ml/g of retained albumin, which is less than the normal water-binding capacity of albumin found in studies in vitro and in some clinical studies. This might be explained by a blocking of the water-binding capacity of the albumin or by the action of other unknown mechanisms, when albumin is given in an amount exceeding the losses. The expansion of the plasma volume did not depend on the concentration of the solutions given but only on the amount of albumin given and the deficit in plasma volume. Since albumin is a good plasma expander and a drug with a few secondary effects it is recommended in the treatment of shock. We prefer the 5% solution, which contains an electrolyte solution and is more easily infused, because of its low viscosity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1028122     DOI: 10.1016/0300-9572(76)90028-9

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  6 in total

Review 1.  Colloid volume expanders. Problems, pitfalls and possibilities.

Authors:  J S Roberts; S L Bratton
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

2.  Fluid volume kinetics of 20% albumin.

Authors:  Robert G Hahn; Markus Zdolsek; Emma Hasselgren; Joachim Zdolsek; Håkan Björne
Journal:  Br J Clin Pharmacol       Date:  2019-03-28       Impact factor: 4.335

3.  Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients.

Authors:  C J Fernandes; N Akamine; F V De Marco; J A De Souza; S Lagudis; E Knobel
Journal:  Crit Care       Date:  2001-11-01       Impact factor: 9.097

Review 4.  Plasma disappearance rate of albumin when infused as a 20% solution.

Authors:  Markus Zdolsek; Patrick Y Wuethrich; Michaela Gunnström; Joachim H Zdolsek; Emma Hasselgren; Christian M Beilstein; Dominique Engel; Robert G Hahn
Journal:  Crit Care       Date:  2022-04-11       Impact factor: 9.097

Review 5.  Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials.

Authors:  Matthias Jacob; Daniel Chappell; Peter Conzen; Mahlon M Wilkes; Bernhard F Becker; Markus Rehm
Journal:  Crit Care       Date:  2008-03-04       Impact factor: 9.097

6.  Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.

Authors:  Heejung Choi; Yoonjung Kim; Soo Min Kim; Junam Shin; Hye Ryoun Jang; Jung Eun Lee; Wooseong Huh; Yoon-Goo Kim; Ha Young Oh; Dae Joong Kim
Journal:  Kidney Res Clin Pract       Date:  2012-04-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.